{"status": "Ok", "redirect_url": "https://www.investor.jnj.com/investor-news/news-details/2026/IMAAVY-nipocalimab-aahu-shows-over-two-years-of-sustained-disease-control-in-a-broad-population-with-generalized-myasthenia-gravis-gMG/default.aspx", "message": "News view counter 675726 successfully enlarged"}